Concord Drugs Ltd SHARE PRICE [LIVE]
BSE: INE858L01010 NSE: CONCORD SECTOR: Pharma
| Open: | |
| High: | |
| Low: |
| MKT Cap: | |
| 52-wk High: | |
| 52-wk Low: |
| Prev close: | |
| P/E: | |
| Div yield: |
Fundamental analysis
What is not working for the company?
What is working for the company?
| Name | Mar 21 | Dec 20 |
|---|
Similar Stocks
Return Calculator
This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.
If I had made LUMPSUM investment of ₹ 1,00,000
in Concord Drugs Ltd
Months ago
My investment would be worth ₹ 1,41,900 with a Gain of 41.90 %
CONCORD News
- FELIX INDUSTRIES LIMITED
- ATHARV ENTERPRISES LIMITED
- NAYSAA SECURITIES LTD
- ABHINAV CAPITAL SERVICES LTD.
- TRITON VALVES LTD.
- TECHINDIA NIRMAN LIMITED
- GODREJ PROPERTIES LTD
- DISH TV INDIA LTD.
- SWARNA SECURITIES LTD.
- GLENMARK LIFE SCIENCE LIMITED
- PANACEA BIOTEC LTD.
- NILKAMAL LTD.
- SYSTEMATIX SECURITIES LIMITEDD
- JATALIA GLOBAL VENTURES LIMITED
- STEEL STRIPS INFRASTRUCTURES LTD.
- LINAKS MICROELECTRONICS LTD.
- JAUSS POLYMERS LTD.
- AVSL INDUSTRIES LIMITED
- NATURA HUE CHEM LTD.
- UNISON METALS LTD
Frequently Asked Questions
What is the Share price of Concord Drugs Ltd (CONCORD)?
Can I buy Concord Drugs Ltd (CONCORD) shares?
How do I buy Concord Drugs Ltd (CONCORD) from Angel One?
- Direct investment: You can buy Concord Drugs Ltd (CONCORD) shares by opening a Demat account with Angel One.
- Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Concord Drugs Ltd (CONCORD) shares.
In which sector do Concord Drugs Ltd (CONCORD) belong?
About CONCORD
Today's live share price for Concord Drugs Ltd is NSE: N/A, BSE: ₹ 28.80 with a current market capitalization of .
CONCORD DRUGS LIMITED is a public limited company established in 1995, is among the respected pharmaceutical companies in India for manufacturing of Finished Pharmaceutical Formulations like Injectables (Small volume parenterals, Dry powder ) ,Tissue Bio-Adhesive, tablets, capsules and ophthalmic preparations and Ready-to-fill Pellets. State of the art technology having dedicated manufacturing facilities for Liquid Injections, Dry powder Injections and Ready-to-fill Pellets ensures the highest level of process integrity and product quality. The company started with Finished Pharmaceutical Formulations and then diversified into Ready-to-fill Pellets, to provide our customers with end-to-end solution to their various pharmaceutical product needs to commercial contract drug manufacturing. The company operates a state of the art, cGMP contract manufacturing Formulation-Fill-Finish facility, providing comprehensive pharmaceutical development and manufacturing services for drug products. The company has two manufacturing facilities built to comply with standards stipulated by Regulatory bodies.
Read more
